2008
DOI: 10.1111/j.1468-1331.2008.02172.x
|View full text |Cite
|
Sign up to set email alerts
|

Beyond neuropathy in hereditary sensory and autonomic neuropathy type V: cognitive evaluation

Abstract: Although newer mutations on this and related disorders are continuously described, their clinical characterization has been restricted to the peripheral aspects of these conditions. A broader characterization of this rare disorder may contribute to better understand the mechanisms of the nociceptive and cognitive aspects of pain.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 40 publications
(66 reference statements)
0
15
0
1
Order By: Relevance
“…HSAN IV patients show a severe pain insensitivity, anhydrosis and mental retardation, which have been interpreted as due to the developmental consequences of lack of trophic support by the NGF/TrkA system to target neurons, including sensory neurons [26]. Importantly, HSAN V patients, differently from HSAN IV patients, while displaying a similar congenital insensitivity to pain, show no mental retardation nor other neurological and cognitive deficits [29], suggesting that neurodevelopmental effects on NGF target neurons, including sensory neurons, are probably minor in HSAN V patients. The single nucleotide missense mutation in the NGFB gene, found in a family of HSAN V patients, who show impaired temperature sensation and an almost complete loss of deep pain perception [27], but normal sweating [30], results in the aminoacid R to W substitution at position 100 of mature NGF protein [27].…”
Section: Introductionmentioning
confidence: 99%
“…HSAN IV patients show a severe pain insensitivity, anhydrosis and mental retardation, which have been interpreted as due to the developmental consequences of lack of trophic support by the NGF/TrkA system to target neurons, including sensory neurons [26]. Importantly, HSAN V patients, differently from HSAN IV patients, while displaying a similar congenital insensitivity to pain, show no mental retardation nor other neurological and cognitive deficits [29], suggesting that neurodevelopmental effects on NGF target neurons, including sensory neurons, are probably minor in HSAN V patients. The single nucleotide missense mutation in the NGFB gene, found in a family of HSAN V patients, who show impaired temperature sensation and an almost complete loss of deep pain perception [27], but normal sweating [30], results in the aminoacid R to W substitution at position 100 of mature NGF protein [27].…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] In HSAN type V, there is severe reduction of unmyelinated nerve fibres and a moderate loss of thin myelinated nerve fibres whereas HSAN type IV show reduced small myelinated nerve fibres and normal large myelinated nerve fibres. 9,10 Self-mutilation and impairment of pain sensation is also seen in conditions such as Lesch-Nyhan syndrome and de Lange syndrome. 11 However HSAN type V can be differentiated from these syndromes by the presence of partial anhydrosis, absence of peripheral nerve thickening and dysmorphic features, a normal serum uric acid level and electrophysiological studies and histopathological findings of nerve fiber loss.…”
Section: Discussionmentioning
confidence: 99%
“…Our patient presents insensitivity to pain, absence of mental retardation and notably self-mutilation of her fingers, lips and tongue. All this clinical manifestations are reported in the literature and found in the rare published cases [1,[4][5][6][7][8]. EMG exploration was in favor of sensitive neuropathy.…”
Section: Discussionmentioning
confidence: 99%
“…Hereditary sensory and autonomic neuropathies (HSAN) are autosomal recessive disorders characterized by the loss of deep pain perception [1]. Six types of sensory neuropathies are reported in the literature [2], with different prevalence and clinical features.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation